Results from the Phase 3 VALOR study and its open-label extension: evaluating the clinical efficacy and safety of tofersen in adults with ALS and confirmed SOD1 mutation - Miller, TC M (American Neruological Association Annual Meeting, 2021)
on behalf of the VALOR Working Group